Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading pharmaceutical and biotechnology companies.
Register your place online at: http://highlypotentapi.com/PR4OPENPR
SMi caught up with Ester Lovsin Barle, Head of Product Stewardship and Health, Takeda Pharmaceutical Company Ltd to discuss her role, priorities, current projects, opportunities, and her involvement as a speaker at the upcoming event.
Considering Highly Potent APIs continues to be an important aspect of pharmaceutical manufacturing, have you seen any changes toward their handling or discussion in the past year?
Health and safety of the employees are still a top priority for our company. On a corporate side we strive to develop and integrate management systems to site operations, especially those that handle compounds that may pose higher risks due to their intrinsic hazards. While there have been many discussions during the COVID-19 pandemic about the relevance of risk vs hazards, the difference is still a challenge to communicate.
What is the greatest challenge for you to personally overcome within the Highly Potent API field currently?
There has been a shift in operations to include new technologies and utilize old technologies in more sustainable manner. At Takeda we strive to be a leader in sustainability. The combination of sustainability thinking, and health protection needs experts from both sides to have a join conversation, not to shift any risks in the value chain. An example about these synergies was published by Schmidt and Guytingco recently in an article titled Ventilation and Sustainable Laboratories (https://synergist.aiha.org/202202-sustainable-laboratories)
What topic will you be addressing in your presentation and what would you say will make it relevant to the audience in 2022?
The topic of safe limits is increasingly reaching the awareness of us all. We know about our planetary limits, and equally we have limits for the chemicals that we are exposed to. I will talk about these limits.
Ester will be presenting on day one of the conference on "Hazards and Potency of New Therapeutic Modalities" which covers:
•Assessment of data relevancy, adequacy, reliability
•Determination of exposure limits in the absence of data
•Case study of nucleic acids
Download the brochure at: http://highlypotentapi.com/PR4OPENPR
SMi offer sponsorship, exhibition, advertising and branding packages, uniquely tailored to compliment you company's marketing strategy, For more details and all delegate enquiries please contact Luke Teachen on +44 (0) 20 7827 6002 or email@example.com
SMi's 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference
Conference: 9th - 10th May 2022
Interactive Workshops: 11th May 2022
India House, 45 Curlew Street
--- ENDS -
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference. here
News-ID: 2599906 • Views: 211
More Releases from SMi Group
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The
Assessing device development and regulation for advanced innovation
Pre Filled Syringes West Coast USA Conference 2022 Launches Assessing device development and regulation for advanced innovation SMi's 6th Annual Conference Pre-Filled Syringes West Coast June 13 - 14, 2022 | San Diego, CA, USA http://www.prefilled-syringes-westcoast.com/ SMi is delighted to announce the 6th annual Pre-Filled Syringes West Coast conference, to be held in San Diego. As part of SMi's leading series of drug delivery device conferences, the 2022 event will provide insights into the rapidly
More Releases for PR4
Due to COVID-19, Pain Therapeutics Conference will be accessed remotely
SMi Group reports: Pain Therapeutics conference will reconvene on 11th and 12 May by remote access. Regarding concerns over COVID-19 SMi's 20th Annual Pain Therapeutics conference will return on the 11th and 12th May 2020 via remote access only. The two-day conference will provide delegates the chance to explore all areas of pain therapeutics, such as pain treatment highlighting clinical success to date as well as evaluating the potential of
10 Key Reasons to attend SMi’s 2nd Annual Pharmaceutical Microbiology East Coa …
In just 3 weeks, the highly anticipated Pharmaceutical Microbiology East Coast conference and exhibition will take place in Boston, USA, on April 10 and 11, 2019. SMi Group are delighted to share 10 key reasons to why you should attend the this event in Boston, next month. This year’s agenda features a series of presentations from industry experts to discuss the key topics in the pharmaceutical microbiology industry such as risk
Exclusive insights into the latest innovations at Drug Discovery Chemistry
SMi Reports: Gain the latest insights into the drug discovery field at the 3rd annual conference on Drug Discovery Chemistry , next month in London. Last month, personal invitations from our conference chairman Roderick E. Hubbard at Vernalis Research were sent inviting interested parties to attend the 3rd Annual Drug Discovery Chemistry Conference, taking place on the 18th and 19th March 2019 in London at the Copthorne Tara Hotel. The
SMi’s 3rd Annual 3D Cell Culture Conference takes place in only 2 weeks
SMi is proud to announce the 3rd Annual 3D Cell Culture conference is returning to London in just under two weeks’ time. Researchers globally are realizing the potential of 3D cell culture for various applications, including testing and discovering new drugs to treat cancer, organ-on-chip models to study the human physiology in an organ specific context, and 3D cell printing to produce organ models. Therefore, this market is likely to
Pharmaceutical Microbiology UK CONFEX takes place in less than a week!
SMi reports: Registration will close in less than week, as the countdown begins for the 8th Annual Pharmaceutical Microbiology UK Conference. The 8th Annual Pharmaceutical Microbiology UK, will take place at the contemporary Coprthorne Tara Hotel in London, on 21 and 22 January 2019. With less than a week remaining, both the pharmaceutical and specialty chemicals industries currently facing both unparalleled opportunities and challenges will gather to address the key
Exclusive interviews released from #milsocialmedia speakers US Army and Canadian …
SMi Group caught up with two speakers for the 8th annual Social Media in the Defence & Military Sector, Ms Lucy Ellis, Communications Advisor at Canadian Department of National Defense and Mr Anthony O'Bryant, Deputy Army Digital Media Division at US Army, to get an insight on their expert point of view. Here is a snippet from their interviews: Anthony O'Bryant, Deputy Army Digital Media Division, US Army Tell us about you